These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY. Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346 [TBL] [Abstract][Full Text] [Related]
7. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group. Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF; Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477 [TBL] [Abstract][Full Text] [Related]
8. REAL-LIFE STUDY IN DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT: The Reldex Study. Malclès A; Dot C; Voirin N; Agard É; Vié AL; Bellocq D; Denis P; Kodjikian L Retina; 2017 Apr; 37(4):753-760. PubMed ID: 27471826 [TBL] [Abstract][Full Text] [Related]
9. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema. Esen E; Sizmaz S; Demircan N Int Ophthalmol; 2017 Feb; 37(1):1-6. PubMed ID: 26968412 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome. Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema. Guigou S; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Matonti F Ophthalmologica; 2015; 233(3-4):169-75. PubMed ID: 25924737 [TBL] [Abstract][Full Text] [Related]
16. Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Dutra Medeiros M; Postorino M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B Ophthalmologica; 2014; 231(3):141-6. PubMed ID: 24356099 [TBL] [Abstract][Full Text] [Related]
17. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study. Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J Retina; 2013; 33(7):1435-40. PubMed ID: 23514796 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity. Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825 [TBL] [Abstract][Full Text] [Related]
20. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial. Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]